Clinical Trial Update: Phase I Study of OPB-51602 in Patients With Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase I trial results are reported for OPB-51602 in patients with hematologic malignancies including multiple myeloma, non-Hodgkin lymphoma, acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• OPB-51602 (OPB-51602)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Multiple Myeloma, Non-Hodgkin Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2015-06-08